Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Project
Targeting the mevalonate pathway to treat inflammatory diseases
Information
Project Team
Outputs and Outcomes
Publications
Myeloid A20 is critical for alternative macrophage polarization and type-2 immune-mediated helminth resistance
Ioanna Petta
Marie Thorp
Maarten Ciers
Gillian Blancke
Louis Boon
Tim Meese
Filip Van Nieuwerburgh
Andy Wullaert
Richard Grencis
Dirk Elewaut
Geert van Loo
Lars Vereecke
et al.
A1
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2024
A20 : a jack of all trades
Pieter Hertens
Geert van Loo
Editorial material
2024
Myeloid OTULIN deficiency couples RIPK3-dependent cell death to Nlrp3 inflammasome activation and IL-1β secretion
Maria Giulia Doglio
Lien Verboom
Emily Ruilova Sosoranga
Ulrika Frising
Tomoko Asaoka
Yannick Gansemans
Filip Van Nieuwerburgh
Geert van Loo
Andy Wullaert
A1
Journal Article
in
SCIENCE IMMUNOLOGY
2023
OTULIN protects the intestinal epithelium from apoptosis during inflammation and infection
Lien Verboom
Christopher Anderson
Maude Jans
Ioanna Petta
Gillian Blancke
Arne Martens
Mozes Sze
Tino Hochepied
Kodi Ravichandran
Lars Vereecke
Geert van Loo
et al.
A1
Journal Article
in
CELL DEATH & DISEASE
2023
Death by TNF : a road to inflammation
Geert van Loo
Mathieu Bertrand
A1
Journal Article
in
NATURE REVIEWS IMMUNOLOGY
2023